Inter partes review (IPR) is an extremely effective alternative or supplement to litigation, and there are appreciable benefits to challenging an issued patent in an IPR rather than before a federal district court. In an IPR, unlike a patent lawsuit, a challenged patent is not presumed to be valid, nor is clear and convincing evidence required to demonstrate invalidity. Rather, the challenger (petitioner) need only ­demonstrate invalidity by a ­preponderance of the evidence.

A petitioner may not, however, avail ­itself of all the defenses available in district court litigation. Rather, IPRs are statutorily limited to challenges “only on a ground that could be raised under Section 102 [novelty] or 103 [obviousness]” and based on only patents and printed publications, according to 35 U.S.C. Section 311(b). Thus, at first glance, it would seem to follow that invalidity defenses, such as indefiniteness under 35 U.S.C. Section 112, can play no role in an IPR.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]